Bupivacaine liposome injectable suspension compared with bupivacaine HCl for the reduction of opioid burden in the postsurgical setting

References

• Apfelbaum JL, Chen C, Mehta SS, et al. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg 2003;97:534-40.
   PubMed Web of Science ®Google Scholar
• Sommer M, de Rijke JM, Van Kleef M, et al. The prevalence of postoperative pain in a sample of 1490 surgical inpatients. Eur J Anaesthesiol 2008;25:267-74.
   PubMed Web of Science ®Google Scholar
• Adamson RT, Lew I, Beyzarov E, et al. Clinical and economic implications of postsurgical use of opioid therapy. Hosp Pharm 2011;46(6 Suppl 1):S4-11.
   Google Scholar
• Pavlin DJ, Chen C, Penaloza DA, et al. Pain as a factor complicating recovery and discharge after ambulatory surgery. Anesth Analg 2002;95:627-34.
   PubMed Web of Science ®Google Scholar
• Chung F, Ritchie E, Su J. Postoperative pain in ambulatory surgery. Anesth Analg 1997;85:808-16.
   PubMed Web of Science ®Google Scholar
• Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology 2004;100:1573-81
   Google Scholar
• White PF. Multimodal pain management – the future is now! Curr Opin Investig Drugs 2007;8:517-18
   PubMed Web of Science ®Google Scholar
• Shang AB, Gan TJ. Optimising postoperative pain management in the ambulatory patient. Drugs 2003;63:855-67.
   PubMed Web of Science ®Google Scholar
• Wheeler M, Oderda GM, Ashburn MA, et al. Adverse events associated with postoperative opioid analgesia: a systematic review. J Pain 2002;3:159-80.
   PubMed Web of Science ®Google Scholar
• Oderda GM, Said Q, Evans RS, et al. Opioid-related adverse drug events in surgical hospitalizations: impact on costs and length of stay. Ann Pharmacother 2007;41:400-6.
   PubMed Web of Science ®Google Scholar
• Oderda GM, Gan TJ, Robinson S, et al. Opioid-related adverse events increase length of stay and drive up total cost of care in a national database of postsurgical patients [abstract]. Presented at: Annual Midyear Clinical Meeting of the American Society of Health-System Pharmacists, 4–8 December 2011, New Orleans, LA, USA.
   Google Scholar
• Jirasiritham S, Tantivitayatan K, Jirasiritham S. Perianal blockage with 0.5% bupivacaine for postoperative pain relief in hemorrhoidectomy. J Med Assoc Thai 2004;87:660-4.
   PubMedGoogle Scholar
• Chester JF, Stanford BJ, Gazet JC. Analgesic benefit of locally injected bupivacaine after hemorrhoidectomy. Dis Colon Rectum 1990;33:487-9.
   PubMed Web of Science ®Google Scholar
• Moiniche S, Mikkelsen S, Wetterslev J, et al. A qualitative systematic review of incisional local anaesthesia for postoperative pain relief after abdominal operations. Br J Anaesth 1998;81:377-83.
   PubMed Web of Science ®Google Scholar
• Haas E, Onel E, Miller H, et al. A double-blind, randomized, active-controlled study for post-hemorrhoidectomy pain management with liposome bupivacaine, a novel local analgesic formulation. Am Surg 2012;78:574-81.
   PubMed Web of Science ®Google Scholar
• Bramlett K, Onel E, Viscusi ER, et al. A randomized, double-blind, dose-ranging study comparing wound infiltration of DepoFoam bupivacaine, an extended-release liposomal bupivacaine, to bupivacaine HCl for postsurgical analgesia in total knee arthroplasty. Knee 2012;19:530-6.
   Google Scholar
• Gorfine SR, Onel E, Patou G, et al. Bupivacaine extended-release liposome injection for prolonged postsurgical analgesia in patients undergoing hemorrhoidectomy: a multicenter, randomized, double-blind, placebo-controlled trial. Dis Colon Rectum 2011;54:1552-9.
   PubMed Web of Science ®Google Scholar
• Smoot JD, Bergese SD, Onel E, et al. The efficacy and safety of DepoFoam® bupivacaine in patients undergoing bilateral, cosmetic, submuscular augmentation mammoplasty: a randomized, double-blind, active-control study. Aesthet Surg J 2012;32:69-76.
   PubMed Web of Science ®Google Scholar
• International Conference on Harmonisation Working Group. ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice E6 (R1). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 10 June 1996, Washington, DC, USA. Available at: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6_R1/Step4/E6_R1__Guideline.pdf [Last accessed: 19 April 2012]
   Google Scholar
• World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. Available at: http://www.wma.net/en/30publications/10policies/b3/17c.pdf [Last accessed 19 April 2012]
   Google Scholar
• Bergese SD, Ramamoorthy S, Patou G, et al. Efficacy profile of liposome bupivacaine, a novel formulation of bupivacaine for postsurgical analgesia. J Pain Res 2012;5:107-16.
   PubMedGoogle Scholar
• Langford RM, Chappell GM, Karrasch JA. A single administration of DepoBupivacaine intraoperatively results in prolonged detectable plasma bupivacaine and analgesia in patients undergoing inguinal hernia repair [abstract P-9088]. Presented at: Annual Postgraduate Assembly in Anesthesiology of the New York State Society of Anesthesiologists, 12–16 December 2008, New York, NY, USA.
   Google Scholar
• White PF, Schooley GL, Ardeleanu M. Analgesia following a single administration of depobupivacaine intraoperatively in patients undergoing inguinal herniorrhaphy: preliminary dose-ranging studies [abstract S-242]. Anesth Analg 2009;108(Suppl 3S):S-242.
   Google Scholar
• Miller H, Terem TM, Kheladze K, et al. A single administration of DepoBupivacaine intraoperatively provides three-day analgesia and reduction in use of rescue opioids in patients undergoing hemorrhoidectomy [abstract]. Presented at: Annual Meeting of the American Society of Colon and Rectal Surgeons, 2–6 May 2009, Hollywood, FL, USA.
   Google Scholar
• Golf M, Daniels SE, Onel E. A phase 3, randomized, placebo-controlled trial of DepoFoam(R) bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy. Adv Ther 2011;28:776-88.
   PubMed Web of Science ®Google Scholar
• Reisine T, Pasternak G. Opioid analgesics and antagonists. In: Hardman JG, Limbard LE, Molinoff PB, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th edn. New York, NY: McGraw-Hill, 1996:521-56
   Google Scholar
• Hutchison RW, Chon EH, Tucker WF, et al. A comparison of a fentanyl, morphine, and hydromorphone patient-controlled intravenous delivery for acute postoperative analgesia: a multicenter study of opioid-induced adverse reactions. Hosp Pharm 2006;41:659-63.
   Google Scholar
• Oderda GM, Evans RS, Lloyd J, et al. Cost of opioid-related adverse drug events in surgical patients. J Pain Symptom Manage 2003;25:276-83.
   PubMed Web of Science ®Google Scholar
• Pizzi LT, Toner R, Foley K, et al. Relationship between potential opioid-related adverse effects and hospital length of stay in patients receiving opioids after orthopedic surgery. Pharmacotherapy 2012;32:502-14.
   PubMed Web of Science ®Google Scholar
• Data on file. Parsippany, NJ, USA: Pacira Pharmaceuticals, Inc., 2011
   Google Scholar
• Paice JA, Gordon DB, Contreras J, et al. Safe use of opioids in hosptials. Sentinel Event Alert 2012;49:1-5.
   PubMedGoogle Scholar
• Hansen BP, Beck CL, Beck EP, et al. Postarthroscopic glenohumeral chondrolysis. Am J Sports Med 2007;35:1628-34.
   PubMed Web of Science ®Google Scholar
• Bailie DS, Ellenbecker TS. Severe chondrolysis after shoulder arthroscopy: a case series. J Shoulder Elbow Surg 2009;18:742-7.
   PubMed Web of Science ®Google Scholar